3628 Data Horizon
- 640
- 00.00%
Data Horizon News
The TOPIX index has risen for 4 consecutive days, supported by strong movements from GENDA.
Tokyo Stock Exchange's Growth Market Index is at 817.49, up 3.32, with a volume of 128.14 million shares and sales of 135.8 billion yen. The TSE Growth Market 250 Index is at 634.66, up 3.17, with a volume of 90.98 million shares and sales of 109.1 billion yen. Today's growth market has seen 4 consecutive increases for both the TSE Growth Market Index and the TSE Growth Market 250 Index. The number of rising stocks is 241, falling stocks is 286, and unchanged stocks is 44. The U.S. stock market on the 11th was mixed. The Dow Jones Industrial Average was down 120.62 dollars.
Data Horizon: Corrected Financial Report - 43rd Term (2022/07/01 - 2023/06/30)
Part 2 of stocks that moved the previous day: Shin-Toh, Abalance, Jii Shii Planning, etc.
Stock name <Code> 6th day closing price ⇒ compared to the previous day Infomart <2492> 305 -18 Small and medium-sized growth stocks are generally lackluster. Takara HD <2531> 1060-24 Although there is no particular material, the level of 1100 yen is also conscious of the milestone. Laser Tech <6920> 34520-1040 Scorpion's report continues to search for lower prices. Euglena <2931> 518-17 The credit-buying side withdraws and sells as the five-day line breaks. Hakuhodo DY
The Tokyo Stock Exchange (TSE) Gross Index fell sharply with attention focused on Astro Scale amid declining interest rates.
Tokyo Stock Exchange Growth Market Index 802.52 -9.93 / volume 166.94 million shares / trading value 174.2 billion yenTokyo Stock Exchange Growth Market 250 Index 623.17 -8.12 / volume 133.5 million shares / trading value 99.8 billion yenToday's growth market saw a sharp decline in both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index. There were 171 rising stocks, 368 falling stocks, and 36 unchanged. The US stock market rose on the 4th. The Dow Jones Average was up 140.26 dollars (+0.
The Tokyo Stock Exchange's Gross Index has rebounded significantly, driven by strong demand for major stocks.
Tokyo Stock Exchange Growth Market Index 812.45 +16.86 / Volume of 122.64 million shares / Trading value of 137.3 billion yen. Tokyo Stock Exchange Growth Market 250 Index 631.29 +14.63 / Volume of 89.12 million shares / Trading value of 109.2 billion yen. Today's growth market saw significant rebound in both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index. There were 425 rising stocks, 124 falling stocks, and 25 stocks remained unchanged. The US stock market on the 3rd was mixed. The Dow Jones Industrial Average fell 115.29 dollars.
The Tokyo Stock Exchange's Gross Index fell slightly, with funds flowing into the main market on the first day.
Tokyo Stock Exchange Growth Market Index 795.59 -0.64 / Volume of 99.65 million shares / Trading value of 98.7 billion yen. TSE Growth Market 250 Index 616.66 -1.83 / Volume of 78.38 million shares / Trading value of 86.1 billion yen. Today's growth market saw a slight decline in both the TSE Growth Market Index and the TSE Growth Market 250 Index. Number of gaining stocks is 290, the decreasing stocks is 244, and unchanged is 40. In the US market on May 31st, Dow Inc was up 574.84 points to 38,686.32 dollars.
The Tokyo Stock Exchange Growth Index rebounded drastically, and major stocks were bought and almost closed at a high price
TSE Growth Market Index 796.23 +18.56/ turnover 128.17 million shares/ trading price 123.8 billion yen TSE growth market 250 index 618.49 +16.22/ turnover 88.52 million shares/ trading price 109.5 billion yen Today's growth market rebounded sharply in both the TSE Growth Market Index and the TSE Growth Market 250 Index. The number of rising stocks is 429, the number of falling stocks is 110, and 33 unchanged. The US stock market continued to decline on the 30th. The Dow average depreciated by $330.06 (
High stop/low stop-down stocks backstage
■Stop High＜3628＞Data Horizon ＜3896＞Awa Paper ＜4499＞Speee ＜4760＞Alpha ＜5380＞Shinto ＜6696＞Truss On Product ＜7073＞Jake ＜9073＞Kyogoku Transport Shoji ■Stop Low※Includes Temporary Stop High/Low (indicative value)
Data Horizon: Confirmation Letter
Data Horizon: Quarterly Report - 44th Quarter 3 (2024/01/01 - 2024/03/31)
Emerging market outlook: Pay attention to financial results announcements from leading companies, will momentum for growth market reviews increase soon
■Emerging markets rebounded from last week to this week (4/30 to 5/10), which will break 100 billion yen for 12 consecutive business days. The gain/fall rate against the 4/26 closing price was almost similar to the Nikkei Average of +0.78%, while the Growth Market Index was +0.80% and the Growth Market 250 Index was +0.87%. In addition to exchange rate fluctuations due to movements seen as yen buying/dollar sales intervention by the Japanese government, financial results announcements for Prime stocks took precedence, etc., the growth market
Brands that moved the day before part 2 Nippon Housing, Japanen, Sansei Technologies, etc.
<コード>Stock name 10-day closing price ⇒ compared to the previous day Alps Alpine ＜6770＞ 1506 -34.5 This fiscal year is expected to continue to decline in regular income. SANKYO ＜6417＞ 1535 -96 profit reduction guidance for the current fiscal year is viewed negatively. Chugoku Paint ＜4617＞ The forecast for a decline in ordinary profit for the current fiscal year 1919-139 is viewed negatively. Nippon Television HD ＜9404＞ 2116 -157.5 Both actual values and guidance are lower than expected. Corowide ＜7616＞ 1899.5 -166 a
Front market [stocks that have moved, stocks that have been created]
*Infocom ＜4348＞ 3485 - It is reported that multiple factions are considering an acquisition. *Alps Logistics ＜9055＞ 5050 Ka - I'm close to the TOB price of Logistics. *Nissin ＜9066＞ 3795 - Due to announcements of drastic dividend increases and implementation of high-level stock buybacks. *Ceres ＜3696＞ 2191 +400 evaluates the high performance change rate for the first quarter. *Tsumura ＜4540＞ 4392 +700 will evaluate the forecast for a significant increase in profit for the current fiscal year. *Jigen ＜3679＞ 652
Brands that moved the day before part 1 Kawasaki Shigeru, GMOTECH, KOSÉ, etc.
<コード>Stock name closing price on the 9th ⇒ Kawasaki Shigeru ＜7012＞ 5607 +70024 business profit decreased by 43.9% compared to the previous day, but it exceeds previous expectations. The forecast for the fiscal year ending 25/3 is 2.8 times that of the previous fiscal year. Miyoshi Oil & Fat ＜4404＞ 1412+157 1st quarter operating profit was 1,233 billion yen. There was a shift from a deficit of 123 million yen in the same period last year to a surplus. Daicel ＜4202＞ announced changes to its 1558.5 +90 shareholder return policy and cancellation of company shares. Data HR ＜3628＞ 630 -10
The TSE Growth Index continues to decline slightly, and there is little sense of direction due to continued weak sales
TSE Growth Market Index 835.99 -3.01/volume 79.72 million shares/trading price 79.8 billion yen TSE growth market 250 index 652.97 -1.92/trading volume 62.39 million shares/trading price 71.3 billion yen Today's growth market continued to decline slightly in both the TSE Growth Market Index and the TSE Growth Market 250 Index. The number of rising stocks is 219, the number of falling stocks is 316, and 38 unchanged. The US stock market on the 8th was mixed. The Dow Jones Industrial Average rose by $172.13 (+0.44)
Emerging Market Stock Digest: Kudan continues to rise drastically for 3 days, data HR is at a year-to-date low
Year-to-date low. The operating profit and loss forecast for the fiscal year ending 24/6 has been revised downward from conventional profit and loss tons to a deficit of 900 million yen (deficit of 498 million yen in the previous fiscal year results). This is because the progress of orders for data health-related services etc. has been delayed, such as taking longer than expected, and sales are expected to fall below previous expectations.
Backstage [stocks that moved, stocks that were made]
*Kawasaki Shigeru ＜7012＞ 5607 +700Business profit for the fiscal year ending 24/3 decreased by 43.9%, but it exceeds previous forecasts. The forecast for the fiscal year ending 25/3 is 2.8 times that of the previous fiscal year. *Miyoshi Oil & Fat ＜4404＞ 1412+157 1st quarter operating profit was 1,233 billion yen. A deficit of 123 million yen in the same period last year turned into a surplus. *Daicel ＜4202＞ announced changes to its 1558.5 +90 shareholder return policy and cancellation of company shares. *Data HR ＜3628＞ Earnings Forecast for the Fiscal Year Ending 630-10624-6
Data HR -- year-to-date low, downward revisions to operating profit and loss forecasts for the fiscal year ending 24/6, delays in processing orders related to data health, etc.
Year-to-date low. The operating profit and loss forecast for the fiscal year ending 24/6 has been revised downward from conventional profit and loss tons to a deficit of 900 million yen (deficit of 498 million yen in previous fiscal year results). This is because the progress of orders for data health-related services etc. has been delayed, such as taking longer than expected, and sales are expected to fall below previous expectations. Continuing investment for medium-term business expansion also became important. The cumulative operating profit and loss for the 3rd quarter (23/7/24 to 3/24) was in deficit of 422 million yen (3.69 for the same period last year)
US long-term interest rates, which are weak and strong, are becoming heavy
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to develop softly. In the US stock market yesterday 8th, the Dow average rose 172.13 dollars (+ 0.44%) to 39,056.39 dollars and continued to rise for 6 days. While buying in anticipation of a good economy supported stock prices, long-term US interest rates rose in response to statements from US financial officials, etc., and weighed on stock prices for high-tech stocks. Today's emerging markets are likely to be dominated by sales. The Dow average continued to rise for 6 days in overseas markets yesterday, but US long-term interest rates
GMOTECH, GMOTECH, etc.
＜3628＞Data HR revised downward, sales forecast for the current fiscal year 4.90 billion yen ← 6.300 billion yen ＜4579＞LaQuoria Drug Discovery Phase I Clinical Trials Begin in Australia ＜4582＞Clinical Trials Targeting Cytomegalovirus Infection After Hematopoietic Stem Cell Transplantation in Phase IIa Clinical Trial (ATHENA Test) with the Synbio Pharmaceutical Injection Brincidofovir Begin Clinical Trials Targeting Cytomegalovirus Infection After Hematopoietic Stem Cell Transplantation ＜6026＞GMOTECH Upward Revised for the Current Fiscal Year ＜6026＞GMOTECH Upward Revised for the Current Fiscal Year Forecast 1,040 million yen ←
Analysis
Price Target
No Data
